Negative symptoms of schizophrenia: a problem that will not go away
- 14 December 2006
- journal article
- review article
- Published by Wiley in Acta Psychiatrica Scandinavica
- Vol. 115 (1), 4-11
- https://doi.org/10.1111/j.1600-0447.2006.00947.x
Abstract
Objective: Negative symptoms of schizophrenia are a common, enduring, and debilitating component of the psychopathology of schizophrenia. Although efforts thus far to elucidate a distinct schizophrenia subtype based upon negative symptoms have yielded mixed results, there are nevertheless neurobiological correlates of the negative symptom typology. Method: A review of nosology, typology, and assessment tools for determining core negative symptoms in schizophrenia. Results: Negative symptoms can be difficult to evaluate objectively. Current rating scales ‘capture’ key domains of negative symptoms, in spite of considerable overlap between these domains. However, each objective assessment trades off methodological rigor and detail against brevity of assessment and ease of use. Conclusion: The description of new methods for measuring these devastating symptoms, coupled with the ongoing development of novel antipsychotics and agents that augment antipsychotics have fuelled renewed interest in the evaluation of negative symptoms and optimism that better treatments for negative symptoms can be found.Keywords
This publication has 43 references indexed in Scilit:
- Treatment of Schizophrenia Negative Symptoms: Future ProspectsSchizophrenia Bulletin, 2006
- Subdomains Within the Negative Symptoms of Schizophrenia: CommentarySchizophrenia Bulletin, 2006
- The NIMH-MATRICS Consensus Statement on Negative SymptomsSchizophrenia Bulletin, 2006
- An Industry Perspective on the NIMH Consensus Statement on Negative SymptomsSchizophrenia Bulletin, 2006
- The Structure of Negative Symptoms Within Schizophrenia: Implications for AssessmentSchizophrenia Bulletin, 2005
- Negative Symptoms and Cognitive Deficits: What Is the Nature of Their Relationship?Schizophrenia Bulletin, 2005
- INVESTIGATING THE NEURODEVELOPMENTAL HYPOTHESIS OF SCHIZOPHRENIAClinical and Experimental Pharmacology and Physiology, 2005
- Food and Drug Administration Perspective on Negative Symptoms in Schizophrenia as a Target for a Drug Treatment ClaimSchizophrenia Bulletin, 2005
- Psychosis prediction: 12-month follow up of a high-risk (“prodromal”) groupSchizophrenia Research, 2002
- Proton Magnetic Resonance Spectroscopy of the Medial Prefrontal Cortex in Patients With Deficit Schizophrenia: Preliminary ReportAmerican Journal of Psychiatry, 2000